この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2020/8/261 分で読めます
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee joint meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. The general function of the committees is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →